PARP1 and cancer: After evaluating the synthetic lethality and underlying cellular stress responses in cancer cells with XRN2 depletion and PARP1 inhibition (Figure 1, Figure 2, Figure 3, Figure 4, Figure 5 and Figure 6), we investigated the cell death pathway employed under these conditions.